AXGN AxoGen, Inc.
$42.16▲ +0.74%
Healthcare
Other
After hours
$42.16▲ +0.00%
Sep 11, 7:30 PM ET
Volume 3.48M
Avg Volume (10D) 1.06M
Key Metrics & Fundamentals
Market Cap
$2.27B
P/E Ratio
–
Div Yield
–%
52W Range
15.27 - 52.91
% vs 50 MA
-6.63%
% vs 200 MA
11.16%
RSI-14
36.4
MACD Histogram
-1.1200
Beta (1Y vs SPY)
0.83
Free Cash Flow
$5.47M
Gross Rev
$69.73M
Gross Profit
$50.67M
EBITDA
-$149,000
COGS
$19.06M
Operating Exp
$52.83M
Operating Income
-$2.16M
EBIT
-$2.16M
Pretax Income
-$1.52M
Net Income
-$1.52M
EPS (Diluted)
-0.03
Price & Volume History
Loading chart…
Recent News
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair
Benzinga · Sep 10, 2026 4:31 PM
2 Medical-Device Stocks Lighting Up the Options Pits
Schaeffer's Investment Research · Sep 10, 2026 2:47 PM
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday Amid Producer Price Inflation Data Release
MT Newswires · Sep 10, 2026 1:17 PM
Sector Update: Healthcare Stocks Mixed Pre-Bell Thursday
MT Newswires · Sep 10, 2026 1:16 PM
Axogen Prices $208.7 Million Public Offering
MT Newswires · Sep 10, 2026 10:41 AM
Axogen to Acquire BioCircuit Technologies for $200 Million
MT Newswires · Sep 10, 2026 10:39 AM
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
GlobeNewswire · Sep 10, 2026 10:01 AM
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
GlobeNewswire · Sep 10, 2026 10:00 AM
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
GlobeNewswire · Sep 1, 2026 11:00 AM
Truist Securities Initiates Axogen at Buy With $60 Price Target
MT Newswires · Aug 26, 2026 9:51 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See AXGN's money flow as a full page
Social Sentiment
No Reddit posts found for AXGN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.